Effect of Allium Cepa in the Management of Shoulder Pain Post Stroke
Effect of Allium Cepa (Onion)in the Management of Shoulder Pain Post Stroke : A Randomized Controlled Trial
1 other identifier
interventional
60
1 country
1
Brief Summary
One of the disabling consequences of stroke is hemipleic shoulder pain. Hemiplegic shoulder pain could be most important hinderance to upper extremity function after stroke . Evidence for rehabilitation approaches for shuolder pain suggested diverse approaches with strong need for further studies. This study planned to investigate the effect of Allium Cepa in the management of shoulder pain post stroke using four arms of the studying with three intervention groups and control group All participants who met study inclusion criteria and gave their consent shall be assessed at baseline for impairment (Fugl Meyer Assessment), activity limitation (Brief Pain Inventory) and participation restrictions (Stroke Impact Scale)
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for early_phase_1 stroke
Started Jun 2018
Shorter than P25 for early_phase_1 stroke
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 11, 2018
CompletedFirst Posted
Study publicly available on registry
March 16, 2018
CompletedStudy Start
First participant enrolled
June 11, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 14, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
June 14, 2019
CompletedNovember 6, 2019
November 1, 2019
1 year
March 11, 2018
November 4, 2019
Conditions
Outcome Measures
Primary Outcomes (2)
Visual Analogue Scale
This was used to assess pain intensity of participants in this study. It is usually 10cm (100mm \[0-4mm no pain, 5-44mm mild pain, 45-74mm moderate pain and 75-100mm severe pain\] in length with two verbal descriptors for the two symptoms extremes. The score ranges from 0-10, with 0 being no pain and 10 pain as bad as possible or worst imaginable pain. Verbal descriptors and numbers at the intermediate points are not recommended in order to avoid clustering of scores around a preferred numeric value.
1 minute
Fugl Meyer Assessment Scale (upper extremity)
This was used to assess the recovery of shoulder joint functional outcome. The items are scored on a 3 points ordinal scale \[0 (cannot perform), 1(performs partially) and 2 (performs fully)\] with maximum score of 226 points. It assesses five domains which include motor function (for upper extremity = 66 and lower extremity = 34), sensory function = 24, balance = 14, joint range of motion = 44 and joint pain = 44. Interpretation of fugyl meyer assessment is as follows 0-35 = very severe, 36-55 = severe, 56-79 = moderate and \>79 mild for motor assessment.
15 minutes
Secondary Outcomes (1)
Stroke Impact Scale
15 minutes
Study Arms (4)
Topical App. of Allium Cepa Extract
EXPERIMENTALIntervention: 5mg of Allium Cepa Extract (Allium Cepa oil) will be applied on the shoulder joint of the participant, followed by kneading massage until the Allium Cepa oil deeply penetrate into the shoulder joint in addition to standard physiotherapy management of shoulder pain post stroke. Three times in a week for four weeks
Phonophoresis of Allium Cepa extract
EXPERIMENTALIntervention: 5mg of Allium Cepa extract (Allium Cepa oil) would be applied on the shoulder joint of the participant, followed by phonophoresis using ultrasound set at at treatment parameter of pulse mode (50%), 1mHz transducer frequency and stroking technique of 1.5w/cm square for 5mins to allow deeper penetration of the Allium Cepa oilinto the joint in addition to standard physiotherapy management of shoulder pain post stroke.Three times in a week for four weeks
Raw mashed Allium Cepa Application
EXPERIMENTALIntervention: 5g or a small size Raw Allium Cepa (onion)bulb will be cut into pieces and then mashed inside pestle and mortar, thereafter the Raw mashed Allium Cepa will then be applied on the surface of the shoulder joint of the participant and then secured with a gauze bandage for 2 hours to allow deeper penetrationin addition to standard physiotherapy management of shoulder pain post stroke. Three times in a week for four weeks
Standard physiotherapy group (SPG)
ACTIVE COMPARATORParticipant in this group will be receiving standard physiotherapy management of shoulder pain post stroke. The standard physiotherapy management will divided into two forms of activities, the first approach is soft tissue manipulation using common massage medium in particular powder would be used in this study. The second approach is the use of therapeutic exercises and this therapeutic exercises will be categorized into three (basic level, intermediate level and advance level of shoulder joint exercises) depending on the stage of recovery of the participants. Three times in a week for four weeks
Interventions
Topical Application of Allium Cepa Extract (oil)
Phonophoresis of Allium Cepa Extract (oil)
Raw Allium Cepa (onion bulb) Mashed
This will consist of Massage and therapeutic exercise for the management of shoulder pain post stroke
Eligibility Criteria
You may not qualify if:
- Stroke survivors with significant cognitive impairment (\< 18 on a mini mental scale) and language impairment that would prevent the patient from answering questions reliably.
- Stroke survivors who had sustained shoulder pain caused by condition other than hemiplegia such as fracture, vertebral origin, dislocation, inflammatory arthritis (rheumatoid and gout) and fibromyalgia.
- Participants who exhibit allergy to Allium Cepa (skin sensitivity or finds the odor offensive).
- Participants who do not agree to use Allium Cepa
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Bayero University Kano, Nigerialead
- Physiotherapy Associatescollaborator
Study Sites (1)
Amina Kano Teaching Hospital
Kano, +234, Nigeria
Related Publications (8)
Cotoi, A., Viana, R., Wilson, R., Chae, J., Miller, T., Foley, N., & Teasell, R.Painful hemiplegic shoulder. Evidence-based review of stroke rehabilitation, 1-56.2016
BACKGROUNDJackson D, Turner-Stokes L, Williams H, Das-Gupta R. Use of an integrated care pathway: a third round audit of the management of shoulder pain in neurological conditions. J Rehabil Med. 2003 Nov;35(6):265-70. doi: 10.1080/16501970310012446.
PMID: 14664316BACKGROUNDDonnan GA, Fisher M, Macleod M, Davis SM. Stroke. Lancet. 2008 May 10;371(9624):1612-23. doi: 10.1016/S0140-6736(08)60694-7.
PMID: 18468545RESULTHoang CL, Salle JY, Mandigout S, Hamonet J, Macian-Montoro F, Daviet JC. Physical factors associated with fatigue after stroke: an exploratory study. Top Stroke Rehabil. 2012 Sep-Oct;19(5):369-76. doi: 10.1310/tsr1905-369.
PMID: 22982823RESULTLundstrom E, Smits A, Terent A, Borg J. Risk factors for stroke-related pain 1 year after first-ever stroke. Eur J Neurol. 2009 Feb;16(2):188-93. doi: 10.1111/j.1468-1331.2008.02378.x. Epub 2008 Dec 9.
PMID: 19138338RESULTNaess H, Lunde L, Brogger J. The effects of fatigue, pain, and depression on quality of life in ischemic stroke patients: the Bergen Stroke Study. Vasc Health Risk Manag. 2012;8:407-13. doi: 10.2147/VHRM.S32780. Epub 2012 Jun 27.
PMID: 22910531RESULTO'Donnell MJ, Diener HC, Sacco RL, Panju AA, Vinisko R, Yusuf S; PRoFESS Investigators. Chronic pain syndromes after ischemic stroke: PRoFESS trial. Stroke. 2013 May;44(5):1238-43. doi: 10.1161/STROKEAHA.111.671008. Epub 2013 Apr 4.
PMID: 23559265RESULTWalsh K. Management of shoulder pain in patients with stroke. Postgrad Med J. 2001 Oct;77(912):645-9. doi: 10.1136/pmj.77.912.645.
PMID: 11571371RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Isa U Lawal, BSc MSc PhD
Bayero University Kano
- PRINCIPAL INVESTIGATOR
Hauwa H Mohammed, BMR,MSc
Bayero University Kano
Study Design
- Study Type
- interventional
- Phase
- early phase 1
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- the outcome assessor will be blinded from knowing the nature of treatment that participants will be recieving either in the intervention groups or control group
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
March 11, 2018
First Posted
March 16, 2018
Study Start
June 11, 2018
Primary Completion
June 14, 2019
Study Completion
June 14, 2019
Last Updated
November 6, 2019
Record last verified: 2019-11